PlainRecalls
FDA Drug Moderate Class II Ongoing

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Reported: August 30, 2023 Initiated: August 14, 2023 #D-1104-2023

Product Description

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Reason for Recall

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Details

Units Affected
Unknown
Distribution
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
Location
Arlington, TX

Frequently Asked Questions

What product was recalled?
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.. Recalled by Inmar Supply Chain Solutions, LLC. Units affected: Unknown.
Why was this product recalled?
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 30, 2023. Severity: Moderate. Recall number: D-1104-2023.